Use of the mouse to unravel allergic asthma: A review of the pathogenesis of allergic asthma in mouse models and its similarity to the condition in humans;Descubriendo el asma de origen alérgico a través del ratón. Un repaso a la patogenia de los modelos de asma alérgica en el ratón y su similitud con el asma alérgica humana

Archivos de Bronconeumologia

Volumn 41, Issue 3, 2005, Pages 141-152

  Torres, R ^a   Picado, C ^b   De Mora, F ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIBODY; CYTOKINE; ICOSANOID; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; METHACHOLINE;

ALLERGIC ASTHMA; ANTIBODY PRODUCTION; BODY PLETHYSMOGRAPHY; BRONCHITIS; BRONCHOSCOPY; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; DISEASE MODEL; EOSINOPHILIA; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN; LUNG BIOPSY; LUNG LAVAGE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; TH2 CELL;

EID: 16344382569     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-2896(05)70605-0     Document Type: Review

References (123)

1. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martínet F, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Resp J. 1995;8:483-91.
2. Office of Press and Public Relations W. WHO: Bronchial asthma. Geneva: World Health Organization, 2000.
3. Martínez-Moratalla J, Almar E, Sunyer J, Ramos J, Pereira A, Payo F, et al. Estudio Europeo del Asma. Identificación y tratamiento de individuos con criterios epidemiólogicos de asma en adultos jóvenes de cinco áreas españolas. Arch Bronconeumol. 1999;35:223-8.
4. Basagana X, Sunyer J, Zock JP, Kogevinas M, Urrutia I, Maldonado JA, et al. Incidence of asthma and its determinants among adults in Spain. Am J Respir Crit Care Med. 2001;164:1133-7.
5. Nolte H, Backer V, Porsbjerg C. Environmental factors as a cause for the increase in allergic disease. Ann Allergy Asthma Immunol. 2001;87:7-11.
6. Kim DS, Drake-Lee AB. Infection, allergy and the hygiene hypothesis: historical perspective. J Laryngol Otol. 2003;117:946-50.
7. Nieto A, Álvarez-Cuesta E, Boquete M, Mazón A, De la Torre F. The cost of asthma treatment in Spain and rationalizing the expense. J Invest Allergol Clin Immunol. 2001;11:139-48.
8. Jarjour NN, Peters SP, Djukanovic R, Calhoun WJ. Investigative use of bronchoscopy in asthma. Am J Respir Crit Care Med. 1998;157:692-7.
9. Kavuru MS, Dweik RA, Thomassen MJ. Role of bronchoscopy in asthma research. Clin Chest Med. 1999;20:153-89.
10. Hoffjan S, Ober C. Present status on the genetic studies of asthma. Curr Opin Immunol. 2002;14:709-17.
11. Brown JR, Kleimberg J, Marini M, Sun G, Bellini A, Mattoli S. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation. Clin Exp Immunol. 1998;114:137-46.
12. Jaffar Z, Roberts K, Pandit A, Linsley P, Djukanovic R, Holgate ST. B7 costimulation is required for IL-5 and IL-13 secretion by bronchial biopsy tissue of atopic asthmatic subjects in response to allergen stimulation. Am J Respir Cell Mol Biol. 1999;20: 153-62.
13. Johnson JR, Wiley RE, Fattouh R, Swirski FK, Gajewska BU, Coyle AJ, et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med. 2004;169:378-85.
14. Motta A, Peltre G, Dormans JA, Withagen CE, Lacroix G, Bois F, et al. Phleum pratense pollen starch granules induce humoral and cell-mediated immune responses in a rat model of allergy. Clin Exp Allergy. 2004;34:310-4.
15. Toward TJ, Broadley KJ. Early and late bronchoconstrictions, airway hyper-reactivity, leucocyte influx and lung histamine and nitric oxide after inhaled antigen: effects of dexamethasone and rolipram. Clin Exp Allergy. 2004;34:91-102.
16. Gascoigne MH, Holland K, Page CP, Shock A, Robinson M, Foulkes R, et al. The effect of anti-integrin monoclonal antibodies on antigen-induced pulmonary inflammation in allergic rabbits. Pulm Pharmacol Ther. 2003;16:279-85.
17. Aoki M, Fukunaga M, Kitagawa M, Hayashi K, Morokata T, Ishikawa G, et al. Effect of a novel anti-inflammatory compound, YM976, on antigen-induced eosinophil infiltration into the lungs in rats, mice, and ferrets. J Pharmacol Exp Ther. 2000;295:1149-55.
18. Barrett EG, Rudolph K, Bowen LE, Muggenburg BA, Bice DE. Effect of inhaled ultrafine carbon particles on the allergic airway response in ragweed-sensitized dogs. Inhal Toxicol. 2003;15: 151-65.
19. Norris CR, Byerly JR, Decile KC, Berghaus RD, Walby WF, Schelegle ES, et al. Allergen-specific IgG and IgA in serum and bronchoalveolar lavage fluid in a model of experimental feline asthma. Vet Immunol Immunopathol. 2003;96:119-27.
20. Bischof RJ, Snibson K, Shaw R, Meeusen ENT. Induction of allergic inflammation in the lungs of sensitized sheep after local challenge with house dust mite. Clin Exp Allergy. 2003;33:367-75.
21. Fornhem C, Peterson CG, Dahlback M, Scheynius A, Alving K. Granulocyte function in the airways of allergen-challenged pigs: effects of inhaled and systemic budesonide. Clin Exp Allergy. 1996;26:1436-48.
22. Van Scott MR, Hooker JL, Ehrmann D, Shibata Y, Kukoly C, Salleng K, et al. Dust mite-induced asthma in cynomolgus monkeys. J Appl Physiol. 2004;96:1433-44.
23. Turlej RK, Fievez L, Sandersen CF, Dogne S, Kirschvink N, Lekeux P, et al. Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-CSF activated STAT5 signalling pathway. Thorax. 2001;56:696-702.
24. Underwood S, Foster M, Raeburn D, Bottoms S, Karlsson JA. Time-course of antigen-induced airway inflammation in the guinea-pig and its relationship to airway hyperresponsiveness. Eur Resp J. 1995;8:2104-13.
25. Isenberg-Feig H, Justice J, Keane-Myers A. Animal models of allergic asthma. Curr Allergy Asthma Rep. 2003;3:70-8.
26. Ali H, Leung KB, Pearce FL, Hayes NA, Foreman JC. Comparison of the histamine-releasing action of substance P on mast cells and basophils from different species and tissues. Int Arch Allergy Appl Immunol. 1986;79:413-8.
27. Wanner A, Mezey RJ, Reinhart ME, Eyre P. Antigen-induced bronchospasm in concious sheep. J Appl Physiol. 1979;47:917-22.
28. Abraham WM, Delehunt JC, Yerger L, Marchette B. Characterization of a late phase pulmonary response after antigen challenge in allergic sheep. Am Rev Respir Dis. 1983;128:839-44.
29. Chen W, Alley MR, Manktelow BW. Airway inflammation in sheep with acute airway hypersensitivity to inhaled Ascaris suum. Int Arch Allergy Appl Immunol. 1991;96:218-23.
30. Chen W, Alley MR, Manktelow BW. Morphological and morphometric studies of the airways of sheep with acute airway hypersensitivity to inhaled Ascaris suum. Int J Exp Pathol. 1991;72:543-51.
31. Bosse J, Boileau R, Begin R. Chronic allergic airway disease in the sheep model: functional and lung-lavage features. J Allergy Clin Immunol. 1987;79:339-44.
32. Johnson HG, Stout BK. Late phase bronchoconstriction and eosinophilia as well as methacholine hyperresponsiveness in Ascaris-sensitive rhesus monkeys were reversed by oral administration of U-83836E. Int Arch Allergy Immunol. 1993;100:362-6.
33. Brewer JP, Kisselgof AB, Martin TR. Genetic variability in pulmonary physiological, cellular, and antibody responses to antigen in mice. Am J Respir Crit Care Med. 1999;160:1150-6.
34. Herz U, Braun A, Ruckert R, Renz H. Various immunological phenotypes are associated with increased airway responsiveness. Clin Exp Allergy. 1998;28:625-34.
35. Shinagawa K, Kojima M. Mouse model of airway remodeling. Strain differences. Am J Respir Crit Care Med. 2003;168:959-67.
36. Cates EC, Gajewska BU, Goncharova S, Álvarez D, Fattouh R, Coyle AJ, et al. Effect of GM-CSF on immune, inflammatory, and clinical responses to ragweed in a novel mouse model of mucosal sensitization. J Allergy Clin Immunol. 2003; 111: 1076-86.
37. Tournoy KG, Kips J, Schou C, Pauwels R. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin Exp Allergy. 2000;30:79-85.
38. Sarpong SB, Zhang L-Y, Kleeberger SR. A novel mouse model of asthma. Int Arch Allergy Immunol. 2003;132:346-54.
39. Sakai K, Yokoyama A, Kohno N, Hiwada K. Effect of different sensitizing doses of antigen in a murine model of atopic asthma. Clin Exp Allergy. 1999;118:9-15.
40. Clarke AH, Thomas WR, Rolland JM, Dow C, O'Brien RM. Murine allergic respiratory responses to the major house dust mite allergen Der p 1. Int Arch Allergy Immunol. 1999; 120: 126-34.
41. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med. 1997;156:766-75.
42. Temelkovski J, Hogan SP, Shepherd DP, Foster P, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacoline responsiveness following chronic exposure to aerosolised allergen. Thorax. 1998;53:849-56.
43. Holt PG, Batty JE, Turner KJ. Inhibition of specific IgE responses in mice by re-exposure to inhaled antigen. Immunology. 1981;42:409-17.
44. Sedgwick JD, Holt PG. Down-regulation of immune responses to inhaled antigen: studies on the mechanism of induced supression. Immunology. 1985;56:635-42.
45. Roberts K, Jaffar Z. Regulation of the adaptative immune response to inhaled allergens [editorial]. Clin Exp Allergy. 2002;32:343-4.
46. Swirski FK, Sajic D, Robbins CS, Gajewska BU, Jordana M. Chronic exposure to innocuous antigen in sensitized mide leads to supressed airway eosinophilia that is reversed by GMC-SF. J Immunol. 2002;169:3499-506.
47. McMillan SJ, Lloyd CM. Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy. 2004;34:497-507.
48. Hamelmann E, Takeda K, Oshiba A, Gelfand EW. Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness-a murine model. Allergy. 1999;54;297-305.
49. Fedan JS, Van Scott MR, Johnson AR. Pharmacological techniques for the in vitro study of airways. J Pharmacol Toxicol Methods. 2001;45:159-74.
50. Martin TR, Gerard NP, Galli SJ, Drazen JM. Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol. 1988;64:2318-23.
51. Takeda K, Hamelmann E, Joetham A, Shultz LD, Larsen GL, Irvin CG, et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med. 1997;186:449-54.
52. Drazen JM, Finn PW, De Sanctis GT. Mouse models of airway hyperresponsiveness: physiological basis of observed outcomes and analysis of selected examples using these outcome indicators. Annu Rev Physiol. 1999;61:593-625.
53. Lundblad LK, Irvin CG, Adler A, Bates JHT. A reevaluation of the validity of unrestrained pletismography in mice. J Appl Physiol. 2002;93:1198-207.
54. Hantos Z, Brusasco V. Assessment of respiratory mechanics in small animals: the simpler the better? J Appl Physiol. 2002;93: 1196-7.
55. Mitzner W, Tankersley C. Interpreting Penh in mice. J Appl Physiol. 2003;94:828-32.
56. Williams MMC, Galli SJ. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med. 2000;192:455-62.
57. Kraneveld AD, Van der Kleij HP, Kool M, Van Houwelingen AH, Weitenberg AC, Redegeld FA, et al. Key role for mast cells in nonatopic asthma. J Immunol. 2002;169:2044-53.
58. Carey MA, Germolec DR, Bradbury JA, Gooch RA, Moorman MP, Flake GP, et al. Accentuated T helper type 2 airway response after allergen challenge in cyclooxygenase-1-/- but not cyclooxygenase-2-/- mice. Am J Respir Crit Care Med. 2003;167: 1509-15.
59. Whitehead GS, Walker JK, Berman KG, Foster WM, Schwanz DA. Allergen-induced airway disease is mouse strain dependent. Am J Physiol Lung Cell Mol Physiol. 2003;285:L32-L42.
60. Melgert BN, Postma DS, Geerlings M, Luinge MA, Klok PA, Van der Strate BW, et al. Short-term smoke exposure attenuates ovalbumin-induced airway inflammation in allergic mice. Am J Respir Cell Mol Biol. 2004;30:880-5.
61. Jungsuwadee P, Dekan G, Stingl G, Epstein M. Recurrent aerosol antigen exposure induces distinct patterns of experimental allergic asthma in mice. Clin Immunol. 2002;102:145-53.
62. Mojtabavi N, Dekan G, Stingl G, Epstein M. Long-lived Th2 memory in experimental allergic asthma. J Immunol. 2002; 169:4788-96.
63. Grootendorst DC, Sont JK, Willems LN, Kluin-Nelemans JC, Van Krieken JH, Veselic-Charvat M, et al. Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies. Clin Exp Allergy. 1997;27: 769-79.
64. Takeda K, Haczku A, Lee J, Irvin CG, Gelfand EW. Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am J Physiol Lung Cell Mol Physiol. 2001;281:L394-L402.
65. Lambrecht BN, Van Rijt LS, Kuipers H. Immunology of eosinophilic airway inflammation: what the animal models teach us. En: Lambrecht BN, Hoogsteden HC, Diamant Z, editors. The immunological basis of asthma. New York: Marcel Dekker; 2003. p. 343-565.
66. Stelts DS, Egan RW, Falcone A, Garlisi CG, Gleich GJ, Kreutner W, et al. Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation. Am J Respir Cell Mol Biol. 1998;18:463-70.
67. Banner KH, Paul W, Page CP. Ovalbumin challenge following immunization elicits recruitment of eosinophils but not bronchial hyperresponsiveness in guinea-pigs: time course and relationship to eosinophil activation status. Pulm Pharmacol. 1996;9:179-87.
68. MacKenzie JR, Mattes J, Dent LA, Foster P. Eosinophils promote allergic disease of the lung by regulating CD4+Th2 lymphocyte function. J Immunol. 2001;167:3146-55.
69. Mattes J, Yang M, Mahalingam S, Kuehr J, Webb DC, Simson L, et al. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med. 2002;195:1433-44.
70. Alam R, Busse WW. The eosinophil - Quo vadis? J Allergy Clin Immunol. 2004;113:38-42.
71. Saini SS. Immune functions of mast cells and basophils. En: Lambrecht BN, Hoogsteden HC, Diamant Z, editors. The immunological basis of asthma. New York: Marcel Dekker; 2003. p. 121-45.
72. Koshino T, Arai Y, Miyamoto Y, Sano Y, Itami M, Teshima S, et al. Airway basophil and mast cell density in patients with bronchial asthma: relationship to bronchial hyperresponsiveness. J Asthma. 1996;33:89-95.
73. Jarjour NN, Calhoun WJ, Schwanz LB, Busse WW. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. Am Rev Respir Dis. 1991;144:83-7.
74. Casale TB, Wood D, Richerson HB, Trapp S, Metzger WJ, Zavala D, et al. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness. J Clin Invest. 1987;79:1197-203.
75. Broide DH, Gleich GJ, Cuomo AJ, Coburn DA, Federman EC, Schwanz LB, et al. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol. 1991;88:637-48.
76. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH. J Exp Med. 2001;193:255-61.
77. 2 as a mediator of allergic asthma. Science. 2000;287:2013-7.
78. Kung TT, Stelts DS, Zurcher JA, Jones H, Umland SP, Kreutner W, et al. Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Mol Biol. 1995;12:404-9.
79. Kumar RK, Foster P. Murine model of chronic human asthma. Immunol Cell Biol. 2001;79:141-4.
80. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161:1720-45.
81. Busse WW, Elias J, Sheppard D, Banks-Schlegel S. Airway re-modeling and repair. Am J Respir Crit Care Med. 1999;140: 1745-53.
82. Rankin JA, Picarella DE, Geba GP, Teman UA, Prasad B, Di-Cosmo B, et al. Phenotypic and physiologic characterization of transgenic mice expressing interleukin-4 in the lung: lynphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Nat Acad Sci. 1996;93:7821-5.
83. Lee J, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE, et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med. 1997;188:1307-20.
84. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest. 1999;103:779-88.
85. Kumar RK, Herbert C, Foster P. Expression of growth factors by airway epithelial cells in a model of chronic asthma: regulation and relationship to subepithelial fibrosis. Clin Exp Allergy. 2004;34:567-75.
86. Garlisi CG, Falcone A, Kung TT, Stelts D, Pennline KJ, Beavis AJ, et al. T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. Clin Immunol Immunopathol. 1995;75:75-83.
87. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med. 1996;183:195-201.
88. Hogan SP, Koskinen A, Matthaei KI, Young IG, Foster PS. Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am J Respir Crit Care Med. 1998;157:210-8.
89. Peebles RSJ, Dworski R, Collins RD, Jarzecka K, Mitchell DB, Graham BS, et al. Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice. Am J Respir Crit Care Med. 2000;162:676-81.
90. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998;282:2261-3.
91. Mattes J, Yang M, Siqueira A, Clark K, McKenzie J, McKenzie AN, et al. IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung. J Immunol. 2001; 167:1683-92.
92. Kumar RK, Herbert C, Yang M, Koskinen AM, McKenzie AN, Foster P. Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma. Clin Exp Allergy. 2002;32:1104-11.
93. Conn L, Homer RJ, Marinov A, Rankin J, Bottomly K. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med. 1997;186:1737-47.
94. Foster PS, Ming Y, Matthei KI, Young IG, Temelkovski J, Kumar RK. Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma. Lab Invest. 2000;80:655-62.
95. Kowalski ML, Pawliczak R, Wozniak J, Siuda K, Poniatowska M, Iwaszkiewicz J, et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med. 2000; 161:391-8.
96. Mullol J, Fernández-Morata JC, Roca-Ferrer J, Pujols L, Xaubet A, Benítez P, et al. Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. J Allergy Clin Immunol. 2002;109:824-30.
97. Chambers LS, Black JL, Ge Q, Carlin SM, Au WW, Poniris M, et al. PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2003;285:L619-L27.
98. Picado C, Bioque G, Roca-Ferrer J, Pujols L, Mullol J, Benítez P, et al. Nuclear factor-kappa B activity is down-regulated in nasal polyps from aspirin-sensitive asthmatics. Allergy. 2003;58:122-6.
99. Gavett SH, Madison SL, Chulada PC, Scarborough PE, Qu W, Boyle JE, et al. Allergic lung responses are increased in prostaglandin H synthase-deficient mice. J Clin Invest. 1999;104: 721-32.
100. Peebles RSJ, Hashimoto K, Morrow JD, Dworski R, Collins RD, Hashimoto Y, et al. Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. Am J Respir Crit Care Med. 2002;165:1154-60.
101. Colville-Nash PR, Gilroy DW. Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammation. BioDrugs. 2001;15:1-9.
102. Kobayashi T, Miura T, Haba T, Sato M, Serizawa I, Nagai H, et al. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J Immunol. 2000;164:3855-61.
103. O'Byrne PM. Leukotriene bronchoconstriction induced by allergen and exercise. Am J Respir Crit Care Med. 2000;161:S68-S72.
104. Hamilton A, Faiferman I, Stober P, Watson RM, O'Byrne PM. Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. J Allergy Clin Immunol. 1998;102:177-83.
105. Henderson WRJ, Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F, et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med. 2002;165: 108-16.
106. Burrows B, Martínez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med. 1989;320:212-7.
107. Humbert M, Grant JA, Taborda-Barata L, Durham SR, Pfister R, Menz G, et al. High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med. 1996;153:1931-7.
108. Campbell AM, Vachier I, Chánez P, Vignola AM, Lebel B, Kochan J, et al. Expression of the high-affinity receptor for IgE on bronchial epithelial cells of asthmatics. Am J Respir Cell Mol Biol. 1998;19:92-7.
109. Mayr SI, Zuberi RI, Zhang M, De Sousa-Hitzler J, Ngo K, Kuwabara Y, et al. IgE-dependent mast cell activation potentiates airway responses in murine asthma models. J Immunol. 2002; 169:2061-8.
110. Milgrom H, Fick RBJ, Su JQ, Reimann JD, Bush RK, Watrous ML, et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. N Engl J Med. 1999;341:1966-73.
111. Mehlhop PD, Van de Rijn M, Goldberg AB, Brewer JP, Kurup VP, Martin TR, et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Nat Acad Sci. 1997;94:1344-9.
112. Hogan SP, Mould A, Kikutani H, Ramsay AJ, Foster P. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J Clin Invest. 1997;99:1329-39.
113. Korsgren M, Erjefalt JS, Korsgren O, Sundler F, Persson CGA. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med. 1997;185:885-92.
114. Wilder JA, Collie DD, Wilson BS, Bice DE, Lyons CR, Lipscomb MF. Dissociation of airway hyperresponsiveness from immunoglobulin E and airway eosinophilia in a murine model of allergic asthma. Am J Respir Cell Mol Biol. 1999;20:1326-34.
115. Brusselle GG, Kips JC, Taverner JH, Van der Heyden JG, Cuvelier CA, Pauwels RA, et al. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy. 1994;24:73-80.
116. MacLean JA, Sauty A, Luster AD, Drazen JM, De Sanctis GT. Antigen-induced airway hyperresponsiveness, pulmonary eosinophilia. and chemokine expression in B cell-deficient mice. Am J Respir Cell Mol Biol. 1999;20:379-87.
117. Gelfand EW. Pro: mice are a good model of human airway disease. Am J Respir Crit Care Med. 2002;166:5-6.
118. Persson CG. Con: mice are not a good model of human airway disease. Am J Respir Crit Care Med. 2002;166:6-7.
119. Zhang Y, Lefort J, Kearsey V, Lapa e Silva JR, Cookson WO, Vargaftig BB. A genome-wide screen for asthma-associated quantitative trait loci in a mouse model of allergic asthma. Hum Mol Genet. 1999;8:601-5.
120. Malm-Erjefalt M, Persson CG, Erjefalt JS. Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation. Am J Respir Cell Mol Biol. 2001;24:352-9.
121. Denzler KL, Borchers MT, Crosby JR, Cieslewicz G, Hines EM, Justice JP, et al. Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J Immunol. 2001;167:1672-82.
122. Persson CG, Erjefalt JS. Degranulation in eosinophils in human, but not in mouse, airways. Allergy. 1999;54:1230-2.
123. Epstein M. Do mouse models of allergic asthma mimic clinical disease? Int Arch Allergy Immunol. 2004;133:84-100.